Larazotide Acetate (AT-1001) 5mg Research Peptide
Larazotide Acetate (AT-1001) is a synthetic eight amino acid peptide widely researched for its role in tight junction regulation and epithelial barrier signaling pathways. Structurally derived from zonula occludens toxin originally associated with Vibrio cholerae, Larazotide has become an important peptide compound within advanced cellular signaling and autoimmune disease research environments.
Research laboratories investigating epithelial barrier communication and tight junction modulation increasingly search for high-purity Larazotide Acetate AT-1001 compounds capable of supporting reproducible laboratory workflows and analytical peptide validation standards.
At https://lavishpeptides.com laboratories can explore premium peptide compounds supported by structured sourcing systems, transparent peptide verification practices, and laboratory-focused peptide research categories.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Larazotide Acetate |
| Alternative Name | AT-1001 |
| Sequence | GGVLVQPG |
| Purity | 95% HPLC-MS |
| Amount | 1mg and 5mg |
| Delivery Format | Freeze Dried |
| Counterion | Acetate |
| C-Terminus | OH |
| N-Terminus | H |
| Application | Flow Cytometry |
| Research Categories | Cell Signaling, Autoimmune Disease |
| Quality Standard | Sterile & Endotoxin Free |
Sequence Information
Amino Acid Sequence
GGVLVQPG
Larazotide Acetate AT-1001 is structurally classified as an octapeptide designed for advanced peptide-mediated cellular communication and epithelial barrier signaling investigations.
Research Applications
Larazotide Acetate AT-1001 is commonly investigated in laboratory environments involving:
- tight junction signaling pathways
- epithelial barrier communication
- cellular signaling frameworks
- autoimmune disease research
- peptide-mediated receptor interactions
- flow cytometry applications
- peptide signaling pathway investigations
As peptide research continues evolving throughout Europe, laboratories increasingly prioritize high-purity peptide compounds capable of supporting reproducible signaling pathway studies and peptide-mediated cellular communication models.
Premium Laboratory Standards
Modern procurement teams evaluating Larazotide Acetate AT-1001 compounds commonly prioritize:
- hplc verified peptides europe
- peptide coa verification eu systems
- analytical hplc data sheets peptides
- 99 percent purity research peptides
- premium peptide laboratory uk standards
- synthetic amino acid chain sequence research
Each batch is manufactured to strict laboratory research standards and supplied:
- sterile
- endotoxin free
- freeze dried
- laboratory research grade
This helps support advanced peptide research workflows requiring analytical consistency and structured peptide verification systems.
Storage Information
For long-term laboratory stability, freeze-dried peptide compounds should be stored under controlled refrigeration conditions away from moisture, excessive heat, and direct UV exposure.
Research laboratories commonly prioritize:
- peptide storage temperature guidelines
- controlled peptide refrigeration systems
- low-moisture laboratory storage
- peptide handling consistency
Following reconstitution, laboratories frequently investigate:
- how long do reconstituted peptides last in fridge
- bacteriostatic water for peptide reconstitution
- peptide reconstitution guide uk
- peptide vial lyophilisate mixing ratio
to improve workflow organization and peptide handling consistency.
Related Research Peptides
Laboratories researching Larazotide Acetate AT-1001 may also investigate:
- https://lavishpeptides.com/product/larazotide-uk/
- https://lavishpeptides.com/product/trx-1-uk/
- https://lavishpeptides.com/product/thymalin-uk/
- https://lavishpeptides.com/product/pnc-27-uk/
- https://lavishpeptides.com/product/semax-uk/
- https://lavishpeptides.com/product/selank-uk/
Disclaimer
All products listed on this website are supplied strictly for laboratory, research, and in vitro scientific purposes only. These compounds are not intended for human consumption, therapeutic applications, medical use, or diagnostic procedures.
Conclusion
Larazotide Acetate AT-1001 continues attracting growing attention throughout the European peptide research market as laboratories increasingly investigate tight junction signaling, epithelial barrier communication, and peptide-mediated cellular interaction pathways. As peptide research evolves, procurement teams searching for high-quality Larazotide compounds now prioritize suppliers capable of supporting premium peptide laboratory uk standards, analytical hplc data sheets peptides, and peptide coa verification eu systems designed for advanced laboratory workflows.
The increasing demand for hplc verified peptides europe and 99 percent purity research peptides reflects broader expansion throughout the peptide industry as laboratories seek reproducible peptide-chain integrity, transparent sourcing systems, and structured analytical verification frameworks. Modern peptide procurement environments now require more than simple batch documentation, with research facilities increasingly evaluating synthetic amino acid chain sequence research standards, laboratory-grade storage systems, and controlled peptide handling protocols before procurement decisions are made.
Research involving Larazotide Acetate AT-1001 continues contributing to broader investigations surrounding peptide-mediated signaling frameworks, receptor-targeted peptide systems, and advanced cellular communication models within modern laboratory environments.
Additional scientific literature involving peptide signaling pathways and epithelial barrier research may also be explored through trusted educational resources including PubMed





Reviews
There are no reviews yet.